Campaign India Team
Dec 15, 2010

Reckitt buys Paras Pharma for Rs 3,260 crores

With this move, Reckitt will have OTC brands like Moov, D’Cold, Dermicool, Krack, among others.

Reckitt buys Paras Pharma for Rs 3,260 crores

Reckitt Benckiser has bought Ahmedabad-based Paras Pharmaceuticals for a Rs. 3,260 crores deal giving it some of the OTC brands including Moov, D’Cold, Dermicool, Krack, Itch Guard, Ring Guard and Set Wet.

Bart Becht, chief executive of Reckitt Benckiser, said, "The acquisition of Paras is another step forward in RB's growth strategy in consumer health care. It creates a material health care business in India, one of the most promising health care markets in the world, with the addition of a number of strong and leading brands."

"We believe the Paras business has not only extremely good growth potential, when supported by RB's investment and innovation strength, we also expect to realize material synergies as a result of the integration of Paras into Reckitt Benckiser.”

"The growth potential of the business, the creation of a material health care business in India's large and growing health care market, and the global synergies available, make Paras an exciting addition to our portfolio and attractive opportunity for our shareholders," he added.

Reckitt had completed the takeover of SSL, which owns the Durex and Scholl brands in November, and showed strong growth in the third quarter of 2010.

Source:
Campaign India

Related Articles

Just Published

2 days ago

HUL, Honasa settle sunscreen campaign lawsuit

HUL to take down digital versions of the campaign; Honasa removes social media posts making a reference to Lakmé.

2 days ago

VDO.AI launches cricket-themed ad formats

Aims to help brands deliver 3x consumer engagement for their IPL ad campaigns.

3 days ago

Global adspend on news brands forecast to decline ...

Creator journalists and UGC are starting to draw more attention from advertisers wary of potentially distressing content on news brands.

3 days ago

Omnicom CEO John Wren dismisses speculation about ...

Wren was speaking at the Q1 earnings call and expects to close the IPG acquisition in H2 2025.